Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardio Diagnostics Holdings Inc. - Common stock (NQ:CDIO)

0.2124 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardio Diagnostics Holdings Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 Next >
Why Is AI-Based Heart Disease Focused Cardio Diagnostics Stock Trading Higher Today?
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) announced the publication of its study in the Journal of the American Heart Association (JAHA), an official journal of the  
Via Benzinga
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Death
Exposures Death
Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
What's Going On With Cardio Diagnostics Stock?
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares were trading lower on Wednesday. 
Via Benzinga
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
Aimil Ltd., one of the companies at the forefront of India’s instrumentation industry, is a leader in introducing innovative technologies to their extensive healthcare network in India. 
Via Benzinga
With New Lab/Operations Hub, Cardio Diagnostics Says it’s Prepared To Meet Uptake In Demand, Announces New Partner Initiative
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results. 
Via Benzinga
With New Lab/Operations Hub, Cardio Diagnostics Says It's Prepared To Meet Uptake In Demand, Announces New Partner Initiative
Nearly 50% of Americans live with diabetes, obesity, hypertension or another major cardiovascular risk, according to the Centers for Disease Control and Prevention (CDC). For many Americans, the first... 
Via Benzinga
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients
From Cardio Diagnostics Holdings, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge... 
Via Benzinga
Why Is Cellectis (CLLS) Stock Up 175% Today?
Cellectis stock is taking off on Wednesday as investors in CLLS react to a massive $245 million investment from AstraZeneca. 
Via InvestorPlace
Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?
Although Cardio Diagnostics scored a major contract for its AI-driven heart disease test, CDIO stock faces a wall of worry. 
Via InvestorPlace
Dow Gains 50 Points; Global Payments Posts Upbeat Earnings
U.S. stocks turned higher toward the end of trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.15% to 32,978.85 while the NASDAQ rose 0.20% to 12,814.52. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Cardio Diagnostics Holdings Stock Is Blasting Higher
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) shares are trading higher Tuesday after the company announced its AI-driven molecular heart disease test has received an 
Via Benzinga
Crude Oil Edges Higher; Caterpillar Earnings Top Views
U.S. stocks edged lower midway through trading, with the S&P 500 trading slightly lower on Tuesday. The Dow traded down 0.11% to 32,892.75 while the NASDAQ fell 0.23% to 12,760.61. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Fall; Pfizer Swings To Q3 Loss
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
By Jeremy Golden, Benzinga 
Via TheNewswire.com
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
--News Direct-- 
Via News Direct
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD
From Cardio Diagnostics Holdings, Inc
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 18 million deaths annually. That amounts to about one-third of all global deaths. 
Via Benzinga
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.